Clinical trial
A Phase I, Prospective, Single-Arm Feasibility Study: Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response (EASY)
NCT06831032 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I, Prospective, Single-Arm Feasibility Study: Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response (EASY)
- Lead sponsor
- University Health Network, Toronto
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 7, 2026
- Completion date
- July 7, 2029
- Enrollment
- 26 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
iliac nodal disease, oligorecurrence, para-aortic lymph node metastasis, para-aortic nodal disease, prostate adenocarcinoma